Показать сокращенную информацию
dc.contributor.author | Starover, A. V. | en |
dc.contributor.author | Godlevska, N. A. | en |
dc.contributor.author | Malinina, O. B. | en |
dc.date.accessioned | 2020-01-30T19:09:12Z | |
dc.date.available | 2020-01-30T19:09:12Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Starover A. V. Clinical experience of local use of vaginal suppositories Proteflazid in the treatment of CIN I-II against the background of the Papillomavirus infection in pregnant women / A. V. Starover, N. A. Godlevska, O. B. Malinina // Матеріали наук.-практ. конф. з міжнар. участю "Сучасні аспекти збереження та відновлення здоров’я жінки", (10-11 трав. 2018 р.). - Вінниця, 2018. - С. 7-8. | uk_UA |
dc.identifier.uri | https://dspace.vnmu.edu.ua/123456789/4303 | |
dc.description.abstract | The issue of timely diagnosis and treatment of pre-tumor cervical pathology remains relevant in modem medical practice. Of particular importance is the problem of cervical intraepithelial neoplasia in pregnant women. Changes the hormonal status, the level of general and local immunity, vaginal'microflora can be a contributing factor in the progression of pathology and the transition to a deeper damage to the cervix during pregnancy. It is also necessary to take into account the impossibility of the use of certain drugs during pregnancy, as well as the limitation of the use of surgical treatment. In this direction, the drug of plant origin Proteflazid in the form of vaginal suppositories is interesting. The product does not have a damaging effect on the embryo / fetus and is authorized for use during pregnancy. | en |
dc.language.iso | en | uk_UA |
dc.subject | Proteflazid | en |
dc.subject | papillomavirus | en |
dc.subject | pregnant | en |
dc.title | Clinical experience of local use of vaginal suppositories Proteflazid in the treatment of CIN I-II against the background of the Papillomavirus infection in pregnant women | en |
dc.type | Article | en |